Healthcare provider profile · identity verified

Michael T Sanford, MD

Family Practice · ROBERTSDALE, AL · NPI 1477530855

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	590	202
Amlodipine Besylate	Amlodipine Besylate	426	147
Lisinopril	Lisinopril	377	123
Levothyroxine Sodium	Levothyroxine Sodium	322	107
Omeprazole	Omeprazole	307	116
Rosuvastatin Calcium	Rosuvastatin Calcium	270	99
Losartan Potassium	Losartan Potassium	226	79
Metformin Hcl	Metformin Hcl	203	76
Albuterol Sulfate Hfa	Albuterol Sulfate	199	53
Gabapentin	Gabapentin	198	78
Hydrochlorothiazide	Hydrochlorothiazide	178	56
Pantoprazole Sodium	Pantoprazole Sodium	165	61
Metoprolol Succinate	Metoprolol Succinate	163	58
Famotidine	Famotidine	131	57
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	39
Duloxetine Hcl	Duloxetine Hcl	117	42
Furosemide	Furosemide	117	49
Simvastatin	Simvastatin	114	37
Potassium Chloride	Potassium Chloride	108	40
Sertraline Hcl	Sertraline Hcl	105	38
Montelukast Sodium	Montelukast Sodium	102	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	36
Tamsulosin Hcl	Tamsulosin Hcl	98	37
Trazodone Hcl	Trazodone Hcl	91	28
Metformin Hcl Er	Metformin Hcl	90	36
Pravastatin Sodium	Pravastatin Sodium	89	29
Citalopram Hbr	Citalopram Hydrobromide	86	23
Metoprolol Tartrate	Metoprolol Tartrate	83	29
Clopidogrel	Clopidogrel Bisulfate	82	26
Allopurinol	Allopurinol	79	22
Celecoxib	Celecoxib	70	33
Carvedilol	Carvedilol	69	26
Meloxicam	Meloxicam	69	32
Fluticasone Propionate	Fluticasone Propionate	67	22
Buspirone Hcl	Buspirone Hcl	61	23
Eliquis	Apixaban	58	19
Glipizide	Glipizide	56	17
Spironolactone	Spironolactone	56	20
Pioglitazone Hcl	Pioglitazone Hcl	55	22
Glipizide Er	Glipizide	53	19
Escitalopram Oxalate	Escitalopram Oxalate	52	16
Fenofibrate	Fenofibrate	51	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Ezetimibe	Ezetimibe	47	21
Jardiance	Empagliflozin	44	16
Amitriptyline Hcl	Amitriptyline Hcl	43	17
Pregabalin	Pregabalin	41	11
Tizanidine Hcl	Tizanidine Hcl	41	19
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	39	suppressed
Glimepiride	Glimepiride	39	12
Atenolol	Atenolol	37	11
Doxycycline Hyclate	Doxycycline Hyclate	37	32
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Hydroxyzine Hcl	Hydroxyzine Hcl	34	13
Propranolol Hcl	Propranolol Hcl	34	12
Ropinirole Hcl	Ropinirole Hcl	33	12
Amoxicillin	Amoxicillin	31	31
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Estradiol	Estradiol	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Ozempic	Semaglutide	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Ibuprofen	Ibuprofen	27	14
Alendronate Sodium	Alendronate Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Finasteride	Finasteride	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Prednisone	Prednisone	26	22
Telmisartan	Telmisartan	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Ondansetron Odt	Ondansetron	23	11
Sucralfate	Sucralfate	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Colchicine	Colchicine	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	20
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Alprazolam	Alprazolam	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Naproxen	Naproxen	18	12
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Nystatin	Nystatin	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Azithromycin	Azithromycin	14	13
Baclofen	Baclofen	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error